IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J. Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark HarrisMaria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James G. McNamara, Jane H. Buckner, Srinath Sanda

Internal Medicine
Inl Med - Endcrn Diabetes Clin

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Sort by
Weight
Alphabetically

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

Fingerprint

Medicine & Life Sciences